(Sharecast News) - Pfizer lifted its full-year guidance on Tuesday after third-quarter numbers beat Wall Street expectations.
The US drug giant said revenues jumped 31% in the three months to September end to $17.7bn, while adjusted diluted earnings per share were $1.06. Analysts had been expecting diluted adjusted EPS of 62...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE